Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials

This publication has 38 references indexed in Scilit:

• Evidence‐Based Recommendations for Antimicrobial Use in Febrile Neutropenia in Japan: Executive Summary
  Clinical Infectious Diseases, 2004
• The Infectious Diseases Society of America 2002 Guidelines for the Use of Antimicrobial Agents in Patients with Cancer and Neutropenia: Salient Features and Comments
  Clinical Infectious Diseases, 2004
• Antimicrobial therapy of unexplained fever in neutropenic patients
  Annals of Hematology, 2003
• Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
  Published by Elsevier ,1998
• Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients
  Journal of Antimicrobial Chemotherapy, 1998
• Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients
  European Journal of Clinical Microbiology & Infectious Diseases, 1993
• Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study
  Antimicrobial Agents and Chemotherapy, 1992
• Aztreonam plus Vancomycin versus Gentamicin plus Piperacillin as Empirical Therapy for the Treatment of Fever in Neutropenic Patients: a Randomised Controlled Study
  Journal of Chemotherapy, 1992
• Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer Patients
  The Journal of Infectious Diseases, 1991
• Empiric Antimicrobial Therapy for Febrile Granulocytopenic Cancer Patients: Lessons from four EORTC trials
  Acta Oncologica, 1988